Item 7.01. Regulation FD Disclosure
A copy of presentation materials describing the Company's business to be used by
the Company at a scientific presentation and from time to time thereafter is
filed as Exhibit 99.1 hereto. These materials reflect updates to information
previously furnished by the Company regarding the Company's research and
development programs, including information relating to expected research and
development milestones. The Company does not intend to file any update of these
presentation materials in the future. The fact that these updated presentation
materials are being furnished should not be deemed an admission as to the
materiality of any information contained in the materials.
The Company has recently received and publicly announced certain clinical data
related to its products. A copy of the press release announcing the data and a
related live conference call and webcast to discuss the data is filed as
Exhibit 99.2 to this Form 8-K and is incorporated herein by reference in its
entirety.
The information in this Item 7.01 and Exhibits 99.1 and 99.2 attached hereto
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, except as shall be expressly set forth
by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following material is filed as an exhibit to this Current
Report on Form 8-K:
Exhibit
Number Document Description
99.1 Ardea Biosciences, Inc. presentation materials date as of October 19,
2009, and to be used from time to time thereafter.
99.2 Press release dated October 19, 2009.
|
Table of Contents
